Advisories For Registrants
May 9th, 2022
COMIRNATY (COVID-19 Vaccine, mRNA, also referred to as Pfizer-BioNTech COVID-19 Vaccine): New Formulation/Presentation for Use in Individuals 12 Years of Age and Older
May 7th, 2022
Sodium Acetate Injection, USP – Potential for the Presence of Particulate Matter
April 15th, 2022
Sotrovimab for Injection – Risk of Treatment Failure due to Circulation of SARS-CoV-2 Omicron BA.2 Subvariant
April 14th, 2022
Distribution of EVUSHELD (tixagevimab and cilgavimab for injection) with English-Only Vial and Carton Labels
Advisories For The Public
May 12th, 2022
Plasma pens are not authorized in Canada and may pose health risks
April 28th, 2022
Apotex recalls Apo-Acyclovir tablets due to a nitrosamine impurity
April 21st, 2022
Pfizer recalls Accupril blood pressure tablets due to a nitrosamine impurity
April 20th, 2022
Health Canada warns about certain hand sanitizers that may pose health risks (Part 2 – March 31, 2021 to present)
Institute for Safe Medication Practices (ISMP) Canada Education Events
Upcoming
- May 14 & 15, 2022 – Incident Analysis and Proactive Risk Assessment
- May 19, 2022 – MedRec and BPMH Training
- June 2 & 3, 2022 – Multi-Incident Analysis and Medication Safety Culture Assessment
Full Program List and eLearning
Institute for Safe Medication Practices (ISMP) Canada Safety Bulletin
Year-to-Date
- January 19, 2022 – ISMP Canada Safety Bulletin Volume 22, Issue 1
- February 28, 2022 – ISMP Canada Safety Bulletin Volume 22, Issue 2
- March 17, 2022 – ISMP Canada Safety Bulletin Volume 22, Issue 3
- March 28, 2022 – ISMP Canada Safety Bulletin Volume 22, Issue 4
- April 20, 2022 – ISMP Canada Safety Bulletin Volume 22, Issue 5
Safe Medication Use Newsletter
Year-to-Date
- January 12, 2022 – Preventing Mistakes with Your Pet’s “Paw-scription”
- February 16, 2022 – Tips for Parents When Medications Need to Be Compounded
- April 13, 2022 – Cannabis for Medical Purposes – Do You Have the Right Product?
